sumatriptan has been researched along with a-317491 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joseph, EK; Levine, JD | 1 |
| Ferrari, LF; Green, PG; Levine, JD | 1 |
2 other study(ies) available for sumatriptan and a-317491
| Article | Year |
|---|---|
Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Endothelial Cells; Endothelin-1; Endothelins; Epinephrine; Hyperalgesia; Male; Octoxynol; Phenols; Polycyclic Compounds; Propanolamines; Purinergic P2X Receptor Antagonists; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Purinergic P2X3; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Tryptamines | 2013 |
Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat.
Topics: Animals; Disease Models, Animal; Endothelial Cells; Female; Hyperalgesia; Male; Mast Cells; Neutrophils; Nitroglycerin; Nociception; Octoxynol; p-Methoxy-N-methylphenethylamine; Pain Threshold; Phenols; Polycyclic Compounds; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sex Factors; Sumatriptan; Surface-Active Agents; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2016 |